Health ❯Vaccines ❯COVID-19

Booster Shots

FDA Authorization Omicron Variant Original Strain FDA Regulations XBB.1.5 Strain Bivalent Booster Dose Bivalent Booster Shots Jill Biden mRNA Technology Eligibility FDA Monitoring Biden Administration Federal Data Federal Stockpile Bivalent Vaccine Eligibility Criteria Immunization Schedule Subvariants Administration Simplification of Vaccination Process Pfizer and Moderna Effectiveness CDC Data Bivalent mRNA Vaccines Annual Vaccination Schedule Omicron Subvariants Bivalent Booster Shot Annual Cycle mRNA Boosters Annual Boosters Bivalent mRNA Boosters Young Children XBB Variants Guidelines Fall Vaccine

ACIP Reconvenes to Vote on Key Vaccine Updates After Two-Month Delay

The panel addresses COVID-19 strategy shifts, RSV vaccine recommendations, and the future of critical public health programs.

COVID Booster Shots This Fall Target New XBB.1.5 Variant

FDA Authorizes Second Dose of Updated Covid Booster for Seniors and Immunocompromised

FDA Approves Second Booster Dose for Vulnerable Populations Amid Concerns Over Waning Immunity